These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12118185)

  • 1. Ligands of the peroxisome proliferator-activated receptor-PPAR-a reduce myocardial infarct size.
    Wayman NS; Ellis BL; Thiemermann C
    Med Sci Monit; 2002 Jul; 8(7):BR243-7. PubMed ID: 12118185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonists of peroxisome-proliferator activated receptor-alpha (clofibrate and WY14643) reduce renal ischemia/reperfusion injury in the rat.
    Sivarajah A; Chatterjee PK; Hattori Y; Brown PA; Stewart KN; Todorovic Z; Mota-Filipe H; Thiemermann C
    Med Sci Monit; 2002 Dec; 8(12):BR532-9. PubMed ID: 12503032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin reduces infarct size in a model of acute myocardial ischemia and reperfusion in the rat.
    Wayman NS; Ellis BL; Thiemermann C
    Med Sci Monit; 2003 May; 9(5):BR155-9. PubMed ID: 12761443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
    Wayman NS; Hattori Y; McDonald MC; Mota-Filipe H; Cuzzocrea S; Pisano B; Chatterjee PK; Thiemermann C
    FASEB J; 2002 Jul; 16(9):1027-40. PubMed ID: 12087064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cardioprotective effects of preconditioning with endotoxin, but not ischemia, are abolished by a peroxisome proliferator-activated receptor-gamma antagonist.
    Sivarajah A; McDonald MC; Thiemermann C
    J Pharmacol Exp Ther; 2005 May; 313(2):896-901. PubMed ID: 15734901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effect of acute treatment with rosiglitazone on rat myocardial ischemia/reperfusion injury by administration method.
    Abe M; Takiguchi Y; Ichimaru S; Kaji S; Tsuchiya K; Wada K
    Eur J Pharmacol; 2008 Jul; 589(1-3):215-9. PubMed ID: 18571644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats.
    Ito K; Shimada J; Kato D; Toda S; Takagi T; Naito Y; Yoshikawa T; Kitamura N
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):530-6. PubMed ID: 15037267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor alpha but not gamma activators.
    Yeh CH; Chen TP; Lee CH; Wu YC; Lin YM; Lin PJ
    Shock; 2006 Sep; 26(3):262-70. PubMed ID: 16912651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of infarct size in a rat model of regional myocardial ischemia and reperfusion by the synthetic peptide DAHK.
    Bar-Or D; McDonald MC; Thiemermann C
    Crit Care Med; 2006 Jul; 34(7):1955-9. PubMed ID: 16691133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
    Ogata T; Miyauchi T; Sakai S; Takanashi M; Irukayama-Tomobe Y; Yamaguchi I
    J Am Coll Cardiol; 2004 Apr; 43(8):1481-8. PubMed ID: 15093887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor alpha agonist, clofibrate, has profound influence on myocardial fatty acid composition.
    Tian Q; Grzemski FA; Panagiotopoulos S; Ahokas JT
    Chem Biol Interact; 2006 Apr; 160(3):241-51. PubMed ID: 16540100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-alpha or -gamma agonists in a type 2 diabetic animal model.
    Kim SK; Zhao ZS; Lee YJ; Lee KE; Kang SM; Choi D; Lim SK; Chung N; Lee HC; Cha BS
    Diabetes Metab Res Rev; 2003; 19(6):487-93. PubMed ID: 14648808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of peroxisome proliferator-activated receptor gamma ligand. Rosiglitazone on left ventricular remodeling in rats with myocardial infarction.
    Geng DF; Wu W; Jin DM; Wang JF; Wu YM
    Int J Cardiol; 2006 Oct; 113(1):86-91. PubMed ID: 16891009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Na+/H+ exchanger inhibition at the onset of reperfusion decreases myocardial infarct size: role of reactive oxygen species.
    Fantinelli JC; Cingolani HE; Mosca SM
    Cardiovasc Pathol; 2006; 15(4):179-84. PubMed ID: 16844548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1.
    Bulhak AA; Sjöquist PO; Xu CB; Edvinsson L; Pernow J
    Basic Res Cardiol; 2006 May; 101(3):244-52. PubMed ID: 16411023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor alpha activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat.
    Banks T; Oyekan A
    J Hypertens; 2008 Mar; 26(3):468-77. PubMed ID: 18300857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes.
    Liang F; Wang F; Zhang S; Gardner DG
    Endocrinology; 2003 Sep; 144(9):4187-94. PubMed ID: 12933694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells.
    Laurora S; Pizzimenti S; Briatore F; Fraioli A; Maggio M; Reffo P; Ferretti C; Dianzani MU; Barrera G
    J Pharmacol Exp Ther; 2003 Jun; 305(3):932-42. PubMed ID: 12649303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of KR-33028, a novel Na+/H+ exchanger-1 inhibitor, on ischemia and reperfusion-induced myocardial infarction in rats and dogs.
    Oh KS; Seo HW; Yi KY; Lee S; Yoo SE; Lee BH
    Fundam Clin Pharmacol; 2007 Jun; 21(3):255-63. PubMed ID: 17521294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT2 receptor blocker sarpogrelate prevents downregulation of antiapoptotic protein Bcl-2 and protects the heart against ischemia-reperfusion injury.
    Rajesh KG; Suzuki R; Maeda H; Murio Y; Sasaguri S
    Life Sci; 2006 Sep; 79(18):1749-55. PubMed ID: 16876202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.